2 completed, 2 enrolling by invitation, 1 not yet recruiting. 2 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Not yet recruiting 1 |
| Phase 3 | 1 | Enrolling by invitation 1 |
Follow Cardiovascular Disease (CKD): new trials by email Literature Review of Cardiovascular Disease (CKD) trials Research Report on Cardiovascular Disease (CKD)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Analysis of the Influence of Dialysis Fluid Composition on Vascular Calcification in Patients With Chronic Kidney Disease Undergoing Hemodialysis Citrate dialysate with magensium supplementation, Acetate dialysate - Vascular Calcification, Hemodialysis | Not applicable | Not yet recruiting | Hospital Clinic of Barcelona | 80 | 2027-01-02 | 2026-09-16 |
| Tongmai Jiangtang Capsule for Cardiovascular Clinical Outcomes in High-Risk Metabolic Syndrome Patients Participants will receive Tongmai Jiangtang Capsule (TJC) in addition to standard treatment., A placebo capsule that is identical in appearance, size, color, formulation, weight, taste, and smell to TJC - Metabolic Syndrome, Cardiovascular Disease (CKD) | Phase 3 | Enrolling by invitation | Guangdong Provincial Hospital of Traditional Chinese Medicine | 530 | 2025-04-24 | 2025-06-13 |
| Coronary Computed Tomography Angiography In Rheumatoid Arthritis Study Rheumatoid Arthritis, Atherosclerotic Ischemic Disease | Enrolling by invitation | Ellen Margrethe Hauge | 4000 | 2024-02-21 | 2026-02-03 | |
| Behavioral Management of Phosphorus in Hemodialysis Patients Education (Edu), SM intervention, Social Cognitive Therapy (SCT) - Cardiovascular Disease (CKD), Hyperphosphatemia | Not applicable | Completed | NYU Langone Health | 40 | 2018-04-23 | 2018-05-31 |
| Alteration of the Risk of CArdiovascular DIseases After Pneumonia Pneumonia, Cardiovascular Disease (CKD) | Completed | Nantes University Hospital | 2000000 | 2015-01-01 | 2026-06-24 |
Cardiovascular Diseases (5) · Anxiety Disorders (1) · Arthritis, Rheumatoid (1) · Cerebrovascular Disorders (1) · Depressive Disorder (1) · Disease (1) · Hyperphosphatemia (1) · Lung Diseases (1) · Lung Neoplasms (1) · Metabolic Syndrome (1) · Pneumonia (1) · Pulmonary Disease, Chronic Obstructive (1) · Respiration Disorders (1) · Vascular Calcification (1)
Metabolic Diseases (3) · Nutritional and Metabolic Diseases (3) · Respiratory Tract Diseases (2) · Arthritis (1) · Autoimmune Diseases (1) · Brain Diseases (1) · Calcinosis (1) · Calcium Metabolism Disorders (1) · Central Nervous System Diseases (1) · Chronic Disease (1) · Connective Tissue Diseases (1) · Disease Attributes (1) · Glucose Metabolism Disorders (1) · Hyperinsulinism (1) · Immune System Diseases (1)
Color (1) · Dosage Forms (1) · Educational Status (1) · Taste (1) · Weights and Measures (1)
Ellen Margrethe Hauge (1) · Guangdong Provincial Hospital of Traditional Chinese Medicine (1) · Hospital Clinic of Barcelona (1) · NYU Langone Health (1) · Nantes University Hospital (1)
China (1) · Denmark (1) · France (1) · United States (1)
Dzenan Masic, MD, PhD (1) · Ellen-Margrethe Hauge, MD, PhD (1) · Mary Sevick, MD (1)
PMID 21470008, PMID 24176437, PMID 26299228, PMID 27075205, PMID 28756037, PMID 30201613, PMID 31882961, PMID 32449782, PMID 32970811, PMID 34166620, PMID 35142896, PMID 42582064